MOESM1 of Basigin-2 upregulated by receptor activator of NF-ÎşB ligand enhances lung cancer-induced osteolytic lesions

Additional file 1: Figure S1. The body weight of mice among the four groups of different treatment. There was no significant difference in the four groups analyzed by 2-way repeated measures ANOVA followed by the Bonferroni test.